Concerns had been raised that government is seemingly opting for the said vaccines — targeting 25 million doses — when it has yet to prove its efficacy and is actually the second most expensive among those being eyed for procurement.
Full Post on Source: Palace insists 'no favorites' on vaccine purchase from drugmakers
